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Obesity, a condition resulting from excess adipose tissue, has an adverse impact 
on health. In recent decades, childhood obesity has increased rapidly in Western 
societies, as well as in developing countries (Chen et al. 2012; Story et al. 2003; 
Yu et al. 2012). However, there is some data suggesting that the prevalence of 
childhood obesity in some European countries has levelled off (Livingstone 
2001). Obesity starting from a relatively young age has been shown to have 
more negative effects on health than obesity starting later in life (Fontaine et al. 
2003). Different studies have reported that childhood obesity is associated with 
increased risk of cardiovascular diseases (Meyer et al. 2006; Raj 2012). On the 
other hand, increased cardiorespiratory fitness is associated with reduced risk of 
cardiovascular diseases (Martins et al. 2010; Rodrigues et al. 2007). Hyper-
lipidemia and impaired glucose tolerance both increase the risk of childhood 
obesity and further cardiovascular diseases (Kim et al. 2010; Schwarzenberg & 
Sinaiko 2006). Excessive fat accumulation in childhood has also been shown to 
be associated with more frequent bone fractures (Dimitri et al. 2010; Ducher et 
al. 2011), indicating a link between adipose tissue and bone tissue. This is 
particularly important during puberty, when bone growth is coupled with 
excessive fat accumulation during this period. Obesity in prepuberty and 
puberty has been found to increase the risk of osteoporosis and obesity later in 
life (Dimitri et al. 2010; Hanks et al. 2010).  
Changes in lifestyle, such as increased sedentary lifestyle, and changes in 
diet, such as increased caloric intake, have been considered to be key factors 
responsible for the continuous increse in the prevalence of childhood obesity 
(Berndtsson et al. 2007; Carlson et al. 2012; Cottrell et al. 2012; Limbers et al. 
2008; Tremblay & Willms 2003). Increased physical activity in childhood, both 
in children with normal weight and in those with obesity, has been found to be 
associated with lower risk of developing cardiovascular diseases in adulthood 
(Berndtsson et al. 2007; Eliakim et al. 2006; Gaeini et al. 2009; Katzmarzyk et 
al. 1999; Mota et al. 2006; Rosa et al. 2011). However, the exact mechanisms as 
to how these changes in lifestyle and diet will lead to the accumulation of fat 
mass (FM) are not yet fully understood. Recent studies have shown that an 
inflammatory process is involved in the development of obesity (Aygun et al. 
2005; Sacheck 2008; Todoric et al. 2011). It has now been established that 
adipose tissue is also a source of various inflammatory markers (Fried et al. 
1998; Lee & Choue 2009). In adulthood, obesity has been found to be 
associated with systemic inflammation (Brinkley et al. 2012; Unek et al. 2010), 
whereas in children the link between obesity and inflammation is not so well 
established. Accordingly, the general aim of this dissertation was to study the 
associations between different serum inflammatory markers and characteristics 
of body composition, bone health, and cardiorespiratory fitness in boys with 




2. REVIEW OF THE LITERATURE 
2.1. General overview of obesity 
According to the World Health Organisation, obesity is defined as a condition 
of abnormal or excessive fat accumulation in adipose tissue to the extent that 
health may be impaired (WHO 2000). Obesity is an increasing health problem 
all around the world and children are a major concern in this trend (Rocher et al. 
2008). Obesity is especially widespread among American children, and has 
significantly increased in recent decades (Skelton et al. 2009; Story et al. 2003). 
Choi et al. (2013) recently described obesity itself or the risk of developing 
obesity as concerning nearly one third of all North American children and 
adults. Obesity is also increasing among Chinese children and adolescents (Yu 
et al. 2012) and in many European countries (Jarosz et al. 2007; Pizarro & 
Royo-Bordonada 2012; Serra 2003). There is little data about the prevalence of 
obesity in Estonian children and adolescents. A study of 9–11-year-old children 
in five European countries showed that the lowest rate of children who were 
overweight was found in Estonian children, compared to Belgian, Cyprian, 
Italian and Swedish children (Pigeot et al. 2009). The other study of children in 
eight European countries aged 2–9 years showed that the lowest percentage of 
overweight children, including those who were obese, was in Estonia, at 13.6% 
(Bammann et al. 2013). 
 It is well known that childhood obesity is associated with increased risk of 
metabolic syndrome (Juonala et al. 2011; Meyer et al. 2006; Raj 2012; Weiss et 
al. 2004). A study of the Danish population showed that higher body weight 
during childhood was associated with an increased risk for coronary heart 
disease in adulthood, and that this association was stronger in boys than in girls 
(Baker et al. 2007). Even a small loss in weight (5–10%) can improve lipid 
profiles, insulin sensitivity, and reduce risk of thrombosis (Aronne & Isoldi 
2007). Larsson et al. (2011) found that overweight Swedish children (aged 10) 
had significantly higher waist circumference (WC), insulin levels, and 
homeostasis model assessment (HOMA) indexes than children of normal 
weight. In this study, BMI correlated positively with fasting insulin levels and 
HOMA index, both well-established risk factors for metabolic syndrome 
(Larsson et al. 2011). A study of Estonian and Swedish children showed that 
improvement in cardiorespiratory fitness throughout childhood and adolescence 
was associated with reduced risk of becoming overweight (Ortega et al. 2011). 
In addition, obesity also affects quality of life, which has been found to be lower 
in obese children than their healthy peers (Pinhas-Hamiel et al. 2006; Quaresma 
et al. 2009). 
In conclusion, obesity among children is an increasing problem all over the 
world with a severe impact on long-term health. Therefore, every new aspect in 
the understanding about the development of obesity and its impact on health 
should improve the effectiveness of interventions to tackle this problem.  
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2.2. Obesity as an inflammatory process 
2.2.1. General overview 
Recent studies have shown that obesity is an inflammatory process (Gordero et 
al. 2012; Heredia et al. 2012; Todoric et al. 2011). Excessive adipose tissue can 
influence the development of inflammation in two ways: Ectopic fat storage 
causes an intracellular inflammatory response and altered adipokine secretion 
by adipocytes. The latter is closely associated with the development of insulin 
resistance, which in the long-term leads to the development of type 2 diabetes. 
A high level of inflammatory markers such as C-reactive protein (CRP) and 
interleukin-6 (IL-6) can predict the development of type 2 diabetes in adults 
(Pradham et al. 2001). Type 2 diabetes and many different cardiovascular 
diseases in adulthood have their roots in childhood: Obesity in childhood 
increases the risk of developing these diseases in adulthood (Balas-Nakash et al. 
2013; De Boer et al. 2013). High serum CRP levels have been shown to be 
associated with higher body mass and being overweight or obese in a large 
population of European children, including Estonians. Children with a higher 
baseline serum CRP concentration showed higher increases in their BMI  
z-scores and central adiposity over time, and were at higher risk of becoming 
overweight or obese during the study (Nappo et al. 2013). Galcheva et al. 
(2011) found that those with increased trunk FM, as measured by WC, had 
significantly higher blood pressure, HOMA index, insulin, total cholesterol and 
triglyceride levels compared to those with normal WC. Serum CRP con-
centration increased proportionally with the degree of abdominal obesity, and, 
after controlling for adiposity, CRP was significantly correlated with systolic 
blood pressure (Galcheva et al. 2011). Central (truncal) adiposity in particular 
has been linked to systemic inflammation and further development of 
atherosclerosis (Festa et al. 2001; Park et al. 2005). Brooks et al. (2010) have 
shown that inflammation is a key factor in the development of atherosclerosis. 
Ridker et al. (2000) found that many inflammatory markers, such as CRP and 
IL-6, were risk factors in predicting future cardiovascular diseases.  
Greater cardiorespiratory fitness in children and adolescents has been found 
to be associated with a lower risk of developing cardiovascular diseases in 
adulthood (Martins et al. 2010; Rodrigues et al. 2007). Ekelund et al. (2007) 
found that cardiorespiratory fitness and physical activity were both inde-
pendently associated with metabolic risk factors in European children, including 
Estonians. A study of Estonian and Swedish children, aged 9–10, showed that 
cardiorespiratory fitness was associated with cardiovascular risk factors more 
strongly than physical activity (Hurtig-Wennlöf et al. 2007). A study of children 
from Portugal, Denmark, and Estonia showed that at least one hour of moderate 
intensity physical activity per day was enough to reduce the risk factors for 
cardiovascular disease (Andersen et al. 2006). High aerobic fitness has been 
found to be associated with low-grade inflammation in 9-year-old children 
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(Steene-Johannessen et al. 2013), as well as in adults aged 55–66 years with 
type 2 diabetes (Jennersjö et al. 2012).  
 
2.2.2. Biochemical inflammatory markers 
White adipose tissue is a biochemically active organ producing different 
hormones and peptides. White adipose tissue from lean individuals secretes 
predominantly anti-inflammatory adipocytokines, such as adiponectin and 
interleukins (interleukin-4 (IL-4), interleukin-10 (IL-10), and interleukin-13 
(IL-13)), whereas adipose tissue from obese individuals produces more pro-
inflammatory adipocytokines, such as tumor necrosis factor-α (TNF-α) and  
IL-6. Different inflammatory markers have been studied in obese adults and 
children. Some of them, such as CRP, IL-6, and TNF-α, have been studied more 
extensively than others (Aygun et al. 2005; Caballero et al. 2008; Ford et al. 
2005; Sacheck 2008; Sumarac-Dumanovic et al. 2009). Inflammatory markers 
such as IL-6, CRP, and TNF-α have been found to be increased in the serum of 
obese children (Alvarez et al. 2009; Arslan et al. 2010; Aygun et al. 2005; 
Caballero et al. 2008; Ford et al. 2005; Herder et al. 2007; Kim et al. 2010; 
Sacheck 2008; Sumarac-Dumanovic et al. 2009).  
Cytokine IL-6 is a pro-inflammatory cytokine that is synthesised in adipose 
tissue. It is also an anti-inflammatory myokine that can be derived from muscle 
tissue (Petersen & Pedersen 2006). This multifunctional cytokine plays a role in 
the inflammatory process, tissue injury, and in the pathogenesis of osteoporosis 
and obesity (reviewed by Papanicolaou et al. 1998). Increased serum IL-6 levels 
have been found in subjects with higher BMI, compared to those with normal 
BMI (Arslan et al. 2010; Aygun et al. 2005; Herder et al. 2007; Kim et al. 
2010). Increased serum IL-6 levels are also associated with increased insulin 
resistance and further development of type 2 diabetes (Arslan et al. 2010).  
C-reactive protein (CRP) is an acute-phase protein and is one of the most 
commonly used inflammatory markers in clinical practice (De Boer 2013; 
Szalai et al. 1997). It can be measured as “classical” CRP (detection limit above 
0.04 mg/L) and also as highly sensitive CRP (hsCRP, detection limit below 
0.04 mg/L). Serum CRP is synthesised in the liver and increases during 
infection, inflammation, or trauma (Du Clos 2000). Elevated serum CRP levels 
may predict further development of type 2 diabetes (Ridker 2007). In addition, 
Calabro et al. (2005) showed that adipocytes can produce CRP under the 
stimulation of several pro-inflammatory cytokines, such as IL-6, TNF-α, and 
IL-β. Furthermore, Ford et al. (2005) found that children and adolescents with 
metabolic syndrome have elevated CRP concentrations. Serum CRP and IL-6 
levels were positively correlated with BMI and body fat percentage in children 
(Parrett et al. 2010). It has been found that adipose tissue is positively correlated 
to serum CRP levels in obese prepubertal children (Parrett et al. 2010). From 
the many studies of inflammatory markers, only serum CRP concentration was 
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positively associated with visceral adipose tissue in a group of overweight 
children (Maffeis et al. 2008).  
Another inflammatory marker, TNF-α, is a multifunctional immunoregu-
latory cytokine (Okamatsu et al. 2009; Sack 2002). This pro-inflammatory 
cytokine has effects in a diverse array of tissues, in cellular differentiation, 
growth, and apoptosis (Sack 2000,Sack 2002), and also a role in the develop-
ment of metabolic syndrome (Plomgaard et al. 2005). This cytokine is produced 
by adipocytes (Okamatsu et al. 2009; Petersen & Pedersen 2006). In addition, 
TNF-α stimulate osteoclast formation in vivo and in vitro (Roodman 2001). 
Higher serum TNF-α levels have been found in obese adult subjects compared 
to lean subjects (Maachi et al. 2004). In children and adolescents the studies 
have given contradictory results. Although Herder et al. (2007) did not find 
correlations between serum TNF-α level and BMI in adolescents, Breslin et al. 
(2012) and Rosa et al. (2011) both found that serum TNF-α levels were 
significantly higher in obese children compared to normal weight children. It 
has also been suggested that elevated serum TNF-α (and also IL-6) levels in 
obese children may indicate an early phase of atherosclerosis (Arslan et al. 
2010). 
Other inflammatory markers, such as interleukin-2 (IL-2), IL-4, interleukin-8 
(IL-8), IL-10, vascular endothelial growth factor (VEGF), interferon-γ (IFN-γ), 
monocyte chemotactic protein-1 (MCP-1), epidermal growth factor (EGF), 
interleukin-1α (IL-1α), and interleukin-1β (IL-1β) have been less investigated 
(Sumarac-Dumanovic et al. 2009; Tam et al. 2010).  
Interleukin-2 (IL-2) is an inflammatory cytokine regulating the immune 
system (Gaffen & Liu 2004). The major function of this marker is to promote 
the spread of CD4+ and CD8+ T-cells (Gaffen & Liu 2004). Diseases such as 
obesity, metabolic syndrome, and atherosclerosis are considered to be 
inflammatory diseases, and T-cells are involved in the pathogenesis of these 
conditions (Łuczynski et al. 2012). Rosa et al. (2011) found that IL-2 levels 
were significantly higher before and throughout a 30-minute intermittent 
exercise test in the overweight group compared to the control group, whereas 
Aygun et al. (2005) found opposite results: Serum IL-2 levels were significantly 
lower in obese children compared to their peers of normal weight.  
Interleukin-4 (IL-4) is an anti-inflammatory cytokine derived from T-cells 
(Okamatsu et al. 2009; Rainsford & Reen 2002), and its main function is to 
activate T- and B-cells (Rainsford & Reen 2002). Rosa et al. (2011) found 
overweight children to show a trend towards higher IL-4 levels compared to 
normal weight peers, but this trend was non-significant. Okamatsu et al. (2009) 
could not detect any IL-4 levels in any of the 99 samples studied for overweight 
or normal weight children. 
Interleukin-8 (IL-8) is a pro-inflammatory cytokine secreted mainly by 
macrophages, but also by endothelial or other epithelial cells, and has roles in 
inflammation, cell recruitment, and lymphoid trafficking (Bosch et al. 2002). 
Cytokine IL-8 can also be derived from the adipocytes (Waters et al. 2007). Its 
4 
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main function is to induce chemotaxis in target cells, causing them to migrate 
toward the site of infection. There are very few studies that look at IL-8 levels 
in obesity. Breslin et al. (2012) and Rosa et al. (2011) did not find a significant 
difference in serum IL-8 levels between children who were overweight and 
those of normal weight. Interestingly, IL-8 may play a role in reducing muscle 
soreness after exercise training (Buford et al. 2009).  
Anti-inflammatory cytokine IL-10 has a role in immunoregulation and 
inflammation. It regulates the release of immune mediators, antigen presen-
tation, and phagocytosis (Sabat et al. 2010). Serum IL-10 also stimulates the 
maturation of B-cells and T-cells (Okamatsu et al. 2009; Sabat et al. 2010). 
Lower levels of serum IL-10 have been associated to states of inflammation, 
tissue injury, and obesity (Arslan et al. 2010). Low IL-10 has been seen in 
patients with obesity, metabolic syndrome, and type 2 diabetes (Arslan et al. 
2010), as well as in obese children and adolescents (Glowinska & Urban 2003; 
Okamatsu et al. 2009).  
The role of MCP-1 is as a chemical messenger (Hillenbrand et al. 2012). 
This protein has an important role in the development of obesity and diabetes, 
by affecting endothelial cells and expanding and remodelling adipose tissue 
(Panee et al. 2012). Higher serum MCP-1 levels have been found in overweight 
children compared with their healthy controls (Breslin et al. 2012), but in 
adolescents no correlation was found between MCP-1 and WC (Herder et al. 
2007). 
Vascular endothelial growth factor (VEGF) is a vascular permeability factor 
that increases the permeability of small blood vessels (Bates et al. 2002). Serum 
VEGF plays a role in the stimulation of vasculogenesis and in the formation of 
the lymphatic vascular system (Tammela et al. 2005). As an angiogenic 
polypeptide, it is involved in the development of many cells, including adipose 
and muscle cells (Claffey et al. 1992). In adults, serum VEGF concentration has 
been found to be correlated with BMI and visceral fat (Loebig et al. 2010; 
Miyazawa-Hoshimoto et al. 2003). In obese children, a trend toward higher 
VEGF levels was found compared to the non-obese subjects, but the difference 
was not statistically significant (Siervo et al. 2012). However, increased BMI 
was associated with increased serum VEGF levels (Siervo et al. 2012).  
Interferon-γ (IFN-γ) is a T-cell-derived cytokine, and its main function is to 
fight against viral and intracellular bacterial infections (Schoenborn et al. 2007). 
It has been suggested that IFN-γ may also be involved in the pathogenesis of 
obesity (Todoric et al. 2011). Serum IFN-γ has been found to be associated with 
Hedgehog signalling in white adipose tissue (Todoric et al. 2011). Studies of 
adults (Sumarac-Dumanovic et al. 2009) and children (Rastogi et al. 2012) did 
not find a significant difference in serum IFN-γ concentration between obese 
and lean subjects. However, the percentage of IFNγ-positive T-helper cells in 
obese children has been positively associated with non-alcoholic steatohepatitis, 
insulin level, and the HOMA index (Pacifico et al. 2006).  
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Epidermal growth factor (EGF) is a growth factor whose role is to stimulate 
cell growth, proliferation, and differentiation (Barnham et al. 1998). Increased 
serum EGF levels have been found in obese children compared to lean children, 
and EGF level correlated with increased BMI (Schipper et al. 2012). 
Two quite similar cytokines belonging to the IL-1 family, IL-1α and IL-1β, 
are involved in inflammation (Tack et al. 2012). They have similar biological 
characteristics, but they vary in terms of localisation, maturation, and secretion 
(Tack et al. 2012). These cytokines bind to IL-1 type I receptors (Tack et al. 
2012). The pro-inflammatory marker IL-1α is produced as a biologically active 
form, while IL-1β reaches its biological activity after contacting the cysteine 
protease caspase-1 (Tack et al. 2012). In addition, IL-1α inhibits insulin 
signalling in adipocytes, whereas IL-1β affects insulin signalling and action by 
targeting the insulin receptor substrate (He et al. 2006; Jager et al. 2007). 
Studies have shown that both markers play an important role in obesity (Tack et 
al. 2012; Um et al. 2011). Um et al. (2011) showed that IL-1α plays a role in the 
development of simple obesity, whereas IL-1β plays a role in the development 
of obesity associated with insulin resistance (Tack et al. 2012). Jung et al. 
(2010) showed a trend in overweight adolescents toward higher serum IL-1α 
levels compared to lean subjects, but this was not statistically significant. Serum 
IL-1β levels have been found to be significantly higher in obese children 
compared to the control group (Aygun et al. 2005). 
 
2.2.3 Interactions between different inflammatory markers 
Various cytokines are related to each other and act on the body as an ensemble. 
Many of them are associated with adipose tissue (Coppack 2001) and the 
immunoregulatory system (Patel et al. 2009). Cytokines are inflammatory 
mediators that may have a pro-inflammatory effect, i.e. aggravate the inflam-
matory response (e.g. IL-6) or have anti-inflammatory properties, i.e. reduce 
inflammation (e.g. IL-10) (Stoner et al. 2013). Chemokines are a large group of 
structurally similar and chemotactically active cytokines, such as IL-8 and 
MCP-1 (Stoner et al. 2013). The cytokines and chemokines are released by 
activated macrophages at the beginning of the inflammatory process (Murphy 
2012). Some cytokines express an inhibitory effect and others stimulatory 
effects on the synthesis of other cytokines, making the systems very complex 
and comprehensive. As mentioned, CRP is synthesised in the liver by 
hepatocytes as part of the acute response to the stimulation by IL-6, and to a 
lesser degree by TNF-α and IL-1β (Calabro et al. 2005; Stoner et al. 2013). For 
example, TNF-α stimulates the production of IL-6 and consequently CRP 
(Petersen & Pedersen 2006; Stephens & Pekala 1991). Cytokine IL-6 anti-
inflammatory effects are demonstrated by stimulating the production of IL-10 
(Petersen & Pedersen 2006). In addition, IFN-γ decreases the production of IL-4 
by the Th2 cells, but it also potently blocks the effects of IL-4 on B-cells 
(Gattoni et al. 2006). Cytokine IL-2 is a growth factor and expansion factor for 
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T-helper cells, and it stimulates the synthesis and production of IL-4, IFN-γ, and 
TNF-α, while IL-10 has an inhibitory effect on IFN-γ, IL-2, and TNF-α (Gaffen 
& Liu 2004; Gattoni et al. 2006; Patel et al. 2009). Serum MCP-1 has been 
found to be involved in attracting monocytes in adipose tissue and to secrete 
pro-inflammatory cytokines such as IL-6, TNF-α and IL-1β in response to  
IFN-γ (Roth et al. 2011).  
Various studies have investigated the associations between different 
biochemical markers. For example, serum IFN-γ levels correlated positively 
with CRP (Patel et al. 2009), IL-6 (Roth et al. 2011), TNF-α (Prondzinsky et al. 
2012), and IL-1β (Roth et al. 2011). Roth et al. (2011) also found that in obese 
children IL-6 was significantly associated with IL-8 and IL-1β, whereas IFN-γ 
was also associated with IL-8 and IL-1β. Serum TNF-α was associated 
significantly with IL-8, MCP-1, and IL-1β levels, and IL-8 with IL-1β in obese 
children (Roth et al. 2011).  
In conclusion, although there have been many studies looking at the role of 
different biochemical markers in the development of obesity, very few studies 
have looked at ten or more biochemical markers simultaneously. Studying a 
large number of different biochemical markers at the same time should give us 
new information about the role of inflammation in the development of obesity. 
 
 
2.3. The impact of obesity  
on bone development in children 
It is well known that the main bone mass acquisition occurs during the first two 
decades of life (Compston 2001). Maximal bone mass acquisition occurs during 
puberty, and about 85–90% of human bone mass is acquired before adulthood 
(Ausili et al. 2012). Body mass has been found to be one of the main determi-
nants of bone mineral density (BMD) (Rhie et al. 2010). However, it appears 
that bone mineral content (BMC) is not different in overweight children com-
pared to normal weight children, even though overweight subjects had slightly 
higher BMC values (Ellis et al. 2003). With the rise in obesity worldwide, there 
is also an ongoing debate about whether excess adiposity has a protective or 
detrimental effect on bone health in children and adults (Dimitri et al. 2012). 
Studies about the impact of body fat on bone health in children have given 
conflicting results (Ackerman et al. 2006; Clark et al. 2006; Dimitri et al. 2010; 
Wey et al. 2011). It has been found that body fat % and trunk fat % are 
negatively correlated with BMD (Lu et al. 2011), while a positive correlation 
between FM and BMC and BMD has been found in prepubertal (Clark et al. 
2006; Cole et al. 2012; Pollock et al. 2010) and pubertal children (Pietrobelli 
et al. 2002; Wang et al. 2007), as well as in adolescents (El Hage et al. 2010; 
Hong et al. 2010). However, other studies have found that obese children had 
lower BMC and BMD after adjustment for their body size when compared to 
normal weight children (El Hage et al. 2010; Goulding 2000; Rocher et al. 
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2008). Fintini et al. (2011) showed that there was a negative impact by obesity 
on BMD in boys aged 12–16 years. Rocher et al. (2008) found that obesity did 
not have a protective effect on bone development in prepubertal children. In 
contrast, Clark et al. (2006) found that FM was a positive independent 
determinant of bone mass and bone size in prepubertal children.  
Being overweight in childhood has been linked to increased risk of future 
bone fractures (Dimitri et al. 2012; Mobley et al. 2005). Overweight children 
with a previous fracture have reduced BMC for their fat free mass (FFM), 
suggesting that FM inhibits bone mineral accrual in children with previous 
fractures (Dimitri et al. 2010). It has also been shown that despite having greater 
bone size, overweight children tend to have reduced volumetric BMD (Cole et 
al. 2012; El Hage et al. 2011; Rocher et al. 2008). While increased FM corre-
lates with increased BMC, it also correlates with lower volumetric BMD (Cole 
et al. 2012). This work suggests that normal weight, overweight, and obese 
children all have slightly different pathways in bone mass acquisition. 
Many serum inflammatory markers, such as IL-6, IL-1β, CRP, and TNF-α, 
have been found to be elevated in obesity (Aygun et al. 2005; Caballero et al. 
2008; Ford et al. 2005; Kim et al. 2010; Sacheck 2008; Sumarac-Dumanovic et 
al. 2009) and associated with bone health (Barbour et al. 2012; Ding et al. 2008; 
Hanks et al. 2010). For example, serum CRP level was found to be a significant 
predictor of osteoporotic fractures in elderly women (Nakamura et al. 2011). 
Increased serum IL-6 concentration has been found to be associated with an 
increased risk for hip fractures in postmenopausal women (Barbour et al. 2012). 
Serum IL-6 levels also predicted bone loss and bone resorption rate in 50–79-
year-old adults, suggesting that targeted inflammation-modulating therapy may 
prevent osteoporosis (Ding et al. 2008). However, there is limited data about the 
role of inflammatory markers in the development of obesity and bone 
accumulation in children (Dimitri et al. 2012; Hanks et al. 2010). Cytokine IL-6 
and tumor necrosis factor receptor-2 (TNFR-2) have been associated with low 
BMC in 7–12-year-old children of normal weight (Hanks et al. 2010). However, 
a study of overweight prepubertal children did not find a significant association 
between BMC and another inflammatory marker, serum CRP levels (Pollock 
2010). Valuable information about the role of different inflammatory markers in 
bone health has been obtained from animal studies (Duque et al. 2011; Zhang et 
al. 2011). For example, Duque et al. (2011) described IFN-γ as being produced 
locally in the bone by cells of immune origin, whereas EGF binding to its 
receptor (EGFR) plays an important role in bone metabolism and bone 
development in mice (Zhang et al. 2011).  
In conclusion, although there are different studies looking at the roles of 
various biochemical markers on bone mass acquisition, very few studies have 
looked at them in concert by using a panel of different biochemical markers. An 
approach using a panel of many markers simultaneously should provide us 
further information about the role of inflammation in bone health.  
5 
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2.4. The impact of obesity on cardiorespiratory  
fitness in children 
Cardiorespiratory fitness is the ability of a subject to perform aerobic exercise. 
Absolute peak oxygen consumption (VO2peak), an accurate measure of aerobic 
capability, is a parameter characterising cardiorespiratory fitness (Gaeini et al. 
2009) and is expressed in l/min. Another parameter used to characterise 
cardiorespiratory fitness is relative VO2peak (VO2peak/kg), which is calculated 
as VO2peak per kilogram of body mass and expressed in ml/min/kg (Berndtsson 
et al. 2007). Many studies have shown that the cardiorespiratory fitness level of 
children is best determined by absolute VO2peak (Gaeini et al. 2009; Nemet et 
al. 2003). The absolute VO2peak increases steadily with age in children and 
adolescents of normal weight, as well as those who are obese (Berndtsson et al. 
2007). In contrast to the normal weight group, no age differences were seen in 
relative VO2peak in obese children and adolescents (Berndtsson et al. 2007). 
Overweight children had significantly lower relative VO2peak than those of 
normal weight (Berndtsson et al. 2007; Eliakim et al. 2006; Esmaeilzadeh et al. 
2012; Gaeini et al. 2009; Rosa et al. 2011). Klasson-Heggebo et al. (2006) 
found that relative VO2peak was associated with WC and the sum of 4 skinfolds 
(SF) in 9-year-old children. In addition, Stratton et al. (2007) found that 
cardiorespiratory fitness level decreased over a 6-year period in both obese and 
normal weight children aged 9–11. However, in daily life activities, relative 
VO2peak/kg is more important than absolute VO2peak. Therefore, although 
obese children may have similar absolute VO2peak values to normal weight 
children, their relative VO2peak values are lower and they perform more poorly 
in weight-dependent physical activities (Berndtsson et al. 2007).  
It is well known that a low level of both cardiorespiratory fitness and 
physical activity has been associated with obesity, many cardiovascular 
diseases, and type 2 diabetes (Llorente-Cantarero et al. 2012). Some investi-
gators have also shown that greater cardiorespiratory fitness in children and 
adolescents is associated with a lower risk of cardiovascular diseases in 
adulthood (Martins et al. 2010; Rodrigues et al. 2007). Children with higher 
levels of physical activity and consequently higher levels of cardiorespiratory 
fitness had better body composition and biochemical markers related to 
cardiovascular disease risk (Cordova et al. 2012). Children and adolescents with 
high cardiorespiratory fitness have better health (Padilla-Moledo et al. 2012) 
and lower frequency of obesity (Byrd-Williams et al. 2008). 
Serum IL-6 and CRP were negatively correlated with relative VO2peak in 
children (Gaeini et al. 2009), as well as in adults (Kullo et al. 2007), whereas 
serum TNF-α levels were positively correlated with absolute VO2peak in 
children (Nemet el al. 2003). Rosa et al. (2011) studied changes in a group of 
different inflammatory markers during an acute cycling exercise by children and 
found that overweight children had higher exaggerated responses of serum IL-6 
and TNF-α levels; however, no correlations were found between resting serum 
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levels of these markers and absolute or relative VO2peak. In 7- to 11-year-old 
boys, cardiorespiratory fitness decreased progressively as BMI increased 
(Esmaeilzadeh et al. 2012).  
In conclusion, although there have been many studies looking at the impact 
of obesity on cardiorespiratory fitness, very few studies have looked at the role 
of different inflammatory markers in these associations. An approach studying 
the relationship between a panel of different biochemical markers and 
cardiorespiratory fitness in obese and normal weight children should provide us 
new information about the role of inflammation in cardiorespiratory fitness 







3. AIMS OF THE STUDY 
The general aim of this dissertation was to study the associations between 
serum inflammatory markers and body composition, bone health, and car-
diorespiratory fitness in boys aged 10–11 years with different BMI values. 
 
The specific aims were:  
1.  to study the levels of serum inflammatory markers between overweight and 
normal weight boys (Study I); 
2.  to examine the relationships between serum levels of inflammatory markers 
and body composition in overweight and normal weight boys (Study I); 
3.  to examine the relationships between serum levels of inflammatory markers 
and bone mineral characteristics in overweight and normal weight boys 
(Study II); 
4.  to examine the relationships between serum levels of inflammatory markers 







The study included 76 Estonian schoolboys aged between 10 and 11 years, who 
were recruited from 11 local schools in Tartu City (n=59) and from 9 schools in 
Tartu County (n=17). The participants were divided into two groups. The 
overweight boys (OWB) group included 36 boys with BMI above the 95th 
centile, and 2 children with BMI between the 85th and 95th centile. The normal 
weight boys (NWB) group included 38 boys with BMI below the 85th centile. 
Each participant and their parents completed a questionnaire about current acute 
or chronic illnesses, and only boys who reported themselves healthy and 
without any acute or chronic illnesses, were recruited. Both groups of boys took 
part in obligatory physical education lessons twice per week at school. Pubertal 
development of the participants was assessed by self-report using an illustrated 
questionnaire according to the Tanner classification (Tanner 1962). All boys 
were in their ordinary everyday diet and they were also asked not to change 
their eating habits. The study was approved by the Medical Ethics Committee at 
the University of Tartu (Estonia), and study participants’ parents signed an 




Body height was measured to the nearest 0.1 cm using Martin`s metal 
anthropometer. Body mass was measured to the nearest 0.05 kg using medical 
electronic scales (A & D Instruments Ltd.; Abingdon, UK). Body mass index 
(BMI) was also calculated (kg/m2). Nine skinfold (SF) (triceps, subscapular, 
biceps, iliac crest, supraspinale, abdominal, front thigh, medial calf, and mid-
axilla) thicknesses were measured on the right side of the body. All SF, waist 
circumference (WC), and hip circumference were measured according to the 
protocol recommended by the International Society for the Advancement of 
Kinantropometry (Marfell-Jones et al. 2006). Waist-to-hip circumference ratio 
(WHR) was calculated as an indicator of body fat distribution. Skinfold 
thickness measurements were taken with a Holtain (Crymmych, UK) skinfold 
caliper. All measured SF were also summarized (sum of 9 SF) as an indicator of 
total subcutaneous body fat.  
 
 
4.3. Bone mineral density and body composition 
Total body (TB) and lumbar spine (LS) bone mineral density (BMD) (g/cm2), 
TB bone mineral content (BMC) (g) and TB bone area (BA) (cm2) were 
measured by dual-energy X-ray absorptiometry (DXA) using the DPX-IQ 
densitometer (DPX-IQ; Lunar Corporation; Madison; WI, USA) and a software, 
6
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version 3.6. Bone mineral apparent density (BMAD) (g/cm3), an estimate of 
volumetric BMD, was calculated as previously described (Katzman et al. 1991): 1) 
TB BMAD = BMC/(TB BA2/body height); 2) LS BMAD = LS BMC/LS BA3/2. 
In addition, the expression of TB BMC for height was calculated to adjust for 
TB bone size (El Hage et al. 2011). TB FM, TB FM percentage (FM %), trunk 
FM, trunk FM % and FFM were also measured by DXA. Participants were 
scanned in light clothing while lying flat on their backs with arms on their sides. 
The fast scan mode and standard subject positioning were used for TB 
measurements. Analysis was performed using an extended analysis option. A 
single examiner evaluated all DXA measurements and results. Intra-subject 




4.4. Maximal exercise testing 
Cardiorespiratory fitness was determined by a stepwise incremental exercise 
test until volitional exhaustion using an electrically braked bicycle ergometer 
(Corival V3; Lode, Netherlands). Initial work rate was 50 W and was 
incremented by 25 W after every 3 min until volitional exhaustion. Pedalling 
frequency was set to 60–70 rpm. Participants were verbally encouraged to 
produce maximal effort. Respiratory gas exchange variables were measured 
throughout the test using breath-by-breath mode with data being recorded in 10 
s intervals. During all tests, the subjects breathed through a facemask. Oxygen 
consumption, carbon dioxide output, and minute ventilation were continuously 
measured using a portable open-air spirometry system (MetaMax I, Cortex, 
Leipzig, Germany). The analyzer was calibrated with gases of known con-
entration before the test according to the manufacturer’s guidelines. All data 
were calculated by means of computer analysis using standard software 
(MetaMax-Analysis 3.21, Cortex). Peak oxygen consumption (VO2peak) 
(l/min) was measured and VO2peak per kilogram of body mass (VO2peak/kg; 
ml/min/kg) was calculated. 
 
 
4.5. Blood analysis 
Blood samples were obtained from a vein before breakfast, between 8 a.m. and 
9 a.m., after an overnight fast. The blood serum was separated and then frozen 
at –80°C for further analysis. Using Evidence® Biochip Technology (Randox 
Laboratories Ltd), interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-6  
(IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), vascular endothelial growth 
factor (VEGF), interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), 
interleukin-1α (IL-1α), interleukin-1β (IL-1β), monocyte chemotactic protein-1 
(MCP-1), epidermal growth factor (EGF), and high sensitive C-reactive protein 
(hsCRP) were measured from fasting serum samples. There were no detection 
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limits or sensitivity problems with any markers measured. The Cytokine and 
Growth Factors High-Sensitivity Array of the Biochip system was used for 
simultaneous quantitative detection of multiple, related cytokine immunoassays 
(in parallel) from a single sample. None of the biochemical markers were below 
detection limits. Intra-assay precision was 5.1–8.5%, and inter-assay precision 
was 5.8–9.9% for all measured markers. Insulin was analysed using Immulite 
2000 (DPC, Los Angeles, USA). The intra- and interassay CVs were less than 
5% and 12%, respectively, at an insulin concentration of 6.6 µU⁄ml. Glucose 
was measured with a commercial kit (Boehringer, Mannheim, Germany). 
Insulin resistance index was calculated using homeostasis model assessment 
(HOMA-IR): fasting insulin (µU⁄ml) x fasting glucose (mmol⁄L)⁄22.5 (Wallace 
et al. 2004).  
 
 
4.6. Statistical analysis 
All statistical analyses were performed with SPSS (Chicago, IL, USA) 15.0 for 
Windows. Standard statistical methods were used to calculate means and 
standard deviations. Evaluation of normality was performed with the Shapiro-
Wilks method. Variables not normally distributed were log-transformed. An 
unpaired, independent two-tailed t-test or Wilcoxon’s (Mann-Whitney) rank-
sum test were used to assess differences in measured parameters between OWB 
and NWB groups. Relationships between inflammatory markers and other 
measured variables were assessed by Pearson correlation analysis. Stepwise 
multiple regression analysis was performed to determine the independent effect 
of the 13 different measured inflammatory parameters on measured body 
composition, bone mineral, and cardiorespiratory fitness characteristics in OWB 






5.1. Body composition, cardiorespiratory fitness,  
and serum inflammatory markers in overweight  
and normal weight boys 
The main characteristics of the participants are presented in Table 1. As 
expected, OWB were taller and heavier, and more frequently in Tanner stage 2 
or 3 than were NWB (34 vs. 28) (Table 1). As expected, mean VO2peak was 
significantly higher and VO2peak/kg significantly lower in OWB than in NWB 
(Table 1). FM and FFM values were significantly higher in OWB compared to 
those in NWB (Table 1). TB BMD, LS BMD, TB BMC, TB BMC for height 
and TB BA were significantly higher, and TB BMAD significantly lower in 
OWB compared to the respective values in NWB (Figure 1). In addition, the 
OWB group had 10 boys who had experienced at least one bone fracture, 
compared to 15 boys in the NWB group, but this difference was not statistically 
significant.  
 







Age (yrs)  11.0±0.8  11.2±0.7  11.1±0.7 
Body height (cm)  146.0±7.5  153.2±7.8*  149.5±8.4 
Body mass (kg)  36.8±5.6  64.5±12.0*  50.3±16.7 
BMI (kg/m2)  17.2±1.7  27.3±3.6*  22.1±5.8 
Sum of 9SF (mm)   75.7±32.5  223.4±44.4*  147.7±83.7 
WC (cm)  60.3±4.9  82.2±8.7*  71.0±13.0 
WHR   0.82±0.04  0.88±0.07*  0.85±0.06 
TB FM %   20.4±7.0  41.9±6.0*  30.8±12.6 
TB FM (kg)  7.3±3.4  26.1±8.4*  16.4±11.4 
TB FFM (kg)  27.6±3.7  35.0±4.9*  31.1±5.7 
Trunk FM %  17.8±7.7  41.3±6.9*  29.1±13.8 
Trunk FM (kg)  2.7±1.6  11.6±4.0*  7.0±5.4 
VO2 peak (l/min)  1.8±0.3  2.1±0.3*  2.0±0.4 
VO2 peak/kg (ml/min/kg)  48.9±6.4   33.7±4.7*  41.1±9.4 














Figure 1. Bone mineral characteristics of the participants (mean ±SD). Significantly 
different between NWB and OWB; * P<0.05.  
 
Out of the 13 inflammation-related markers, OWB had significantly higher 
serum IL-6, IL-8, IFN-γ, MCP-1 and hsCRP values compared to NWB 
(Table 2). In addition, OWB had significantly lower blood glucose, but 






































































IL-2 (pg/ml)  1.8±0.9  1.7±0.8  1.8±0.8 
IL-4 (pg/ml)  2.2±1.1  2.3±1.3  2.2±1.2 
IL-6 (pg/ml)  0.8±0.3  1.1±0.6*  1.0±0.5 
IL-8 (pg/ml)  7.7±2.9  9.5±3.6*  8.6±3.3 
IL-10 (pg/ml)  0.8±0.4  0.7±0.2  0.8±0.3 
VEGF (pg/ml)  94.0±61.1  111.6±59.7  102.6±60.6 
IFN-γ (pg/ml)  1.5±1.0  2.2±1.2*  1.8±1.1 
TNF-α (pg/ml)  4.3±2.0  4.8±1.8  4.6±1.9 
IL-1α (pg/ml)  0.2±0.3  0.4±0.4  0.3±0.3 
IL-1β (pg/ml)  1.3±0.7  1.4±0.7  1.3±0.7 
MCP-1 (pg/ml)  165.8±67.9  212.8±58.0*  188.7±67.2 
EGF (pg/ml)  22.8±17.4  25.4±15.0  24.1±16.2 
hsCRP (mg/L)   1.0±0.2  2.3±2.1*  1.6±1.6 
Insulin (mU/L)  4.0±2.2  11.9±4.8*  7.5±5.5 
Glucose (mmol ⁄ L)  5.4±0.4  4.9±0.4*  5.2±0.5 
HOMA-IR  0.9±0.6  2.6±1.1*  1.7±1.2 
* Significantly different between NWB and OWB group; P<0.05. 
 
 
5.2. Relationships between serum inflammatory markers 
and body composition characteristics 
Pearson correlation coefficients between body height, body mass, BMI, WC, 
WHR, sum of 9 SF, Tanner stages (Table 3), TB FM %, TB FM, trunk FM %, 
trunk FM (Table 4), and serum inflammatory parameters and insulin-resistance 
markers were calculated. BMI correlated significantly with TNF-α (r= 0.39, 
P<0.05) and hsCRP (r= 0.38, P<0.05) in OWB. WC correlated positively with 
IL-6 (r= 0.35, P<0.05) in OWB and negatively with IL-4 (r= –0.32, P<0.05) in 
NWB. Insulin (r= 0.35, P<0.05) and HOMA-IR (r= 0.34, P<0.05) correlated 
with WC only in NWB. Tanner stage and WHR were not significantly 
correlated with any inflammatory parameters in OWB. Tanner stage was 
negatively correlated to insulin (r= –0.34, P<0.05) and HOMA-IR (r= –0.38, 
P<0.05) in OWB (Table 3).  
Skinfold thickness correlated more significantly with inflammatory markers 
in OWB than in NWB. The sum of 9 SF thickness measurements correlated 
significantly only with IL-6 (r= 0.33, P<0.05) and TNF-α (r= 0.38, P<0.05) in 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































IL-6 correlated with all body composition parameters in OWB and with trunk 
FM in NWB (Table 4). In OWB, TNF-α correlated significantly with all four 
body composition parameters (TB FM %, TB FM, trunk FM %, and trunk FM). 
Additionally, IFN-γ significantly correlated with TB FM % (r= 0.34, P<0.05) 
and TB FM (r= 0.36, P<0.05) in OWB (Table 4).  
There were significant positive correlations between insulin and TB FM 
(r= 0.33, P<0.05), and between HOMA-IR and TB FM (r= 0.32, P<0.05), 
between insulin and trunk FM (r= 0.34, P<0.05), between HOMA-IR and trunk 
FM (r= 0.32, P<0.05) in NWB (Table 4). 
The results of the stepwise multiple regression analysis are shown in 
Table 5. 38.8% of the variability of TB FM was explained by a combination of 
TNF-α, IFN-γ, and hsCRP levels (Table 5).  
 
Table 5. Results of stepwise multiple regression analysis where BMI, TB FM, TB 
FM %, trunk FM, trunk FM %, and sum of SF were used as dependent variables and 13 
biochemical markers as independent variables.  
Group  NWB OWB Total 
BMI TNF-α – 12.5% – 
 TNF-α, hsCRP – 20.3% – 
 TNF-α, hsCRP, IFN-γ – 29.7% – 
 Insulin – – 50.0% 
 Insulin, glucose – – 59.4% 
 Insulin, glucose, hsCRP – – 65.1% 
 Insulin, glucose, hsCRP, IL-8 – – 66.6% 
TB FM Insulin 8.3% – – 
 TNF-α – 18.8% – 
 TNF-α, hsCRP – 30.3% – 
 TNF-α, hsCRP, IFN-γ – 38.8% – 
 Insulin – – 50.5% 
 Insulin, Il-6 – – 57.8% 
 Insulin, Il-6, glucose – – 63.1% 
 Insulin, Il-6, glucose, hsCRP  – 65.7% 
TB FM % TNF-α – 20.1% – 
 TNF-α, IFN-γ – 26.4% – 
 TNF-α, IFN-γ, hsCRP – 38.2% – 
 Insulin – – 50.1% 
 Insulin, glucose – – 57.2% 





Table 5. Results of stepwise multiple regression analysis where BMI, TB FM, TB 
FM %, trunk FM, trunk FM %, and sum of SF were used as dependent variables and 13 
biochemical markers as independent variables. Continuation. 
Group  NWB OWB Total 
Trunk FM IL-6 9.0% 17.5% – 
 IL-6, insulin 17.8% – – 
 IL-6, IFN-γ – 25.3% – 
 Insulin – – 52.2% 
 Insulin, IL-6 – – 60.6% 
 Insulin, IL-6, glucose – – 64.4% 
Trunk FM % IL-6 – 18.2% – 
 IL-6, IFN-γ – 26.2% – 
 Insulin – – 49.4% 
 Insulin, IL-6 – – 56.9% 
 Insulin, IL-6, glucose – – 62.0% 
Sum of 9 SF IL-6 7.9% – – 
 TNF-α – 11.4% – 
 Insulin – – 51.7% 
 Insulin, glucose – – 60.1% 
 Insulin, glucose, IL-6 – – 65.8% 
R2 × 100 is shown describing the percentage of variability of the dependent variables the 
inflammatory marker alone or together with others can explain. All values are in percentages. 
 
 
5.3. Relationships between serum inflammatory  
markers and bone mineral characteristics 
Pearson’s correlation showed only a few significant correlations between 
inflammation markers and BMD characteristics (Table 6; Figure 2). In the 
OWB group, IFN-γ was significantly (P<0.05) correlated with TB BMD  
(r= 0.36), TB BMC (r= 0.38), and BMC for height (r= 0.53). Serum hsCRP 
concentration was correlated with TB BMD (r= 0.40), IL-10 with TB BMD  
(r= 0.31), IL-1α with BMC for height (r= 0.33), and EGF with BMC for height 
(r= –0.33). In the NWB group, serum IL-4 (r= –0.32), IL-10 (r= –0.39) and IL-
1α (r= –0.37) levels were correlated with TB BMC, and serum EGF correlated 
with LS BMAD (r= 0.32). All other relationships between measured 
inflammatory parameters and BMD characteristics were not statistically signi-
ficant.  
In stepwise multiple regression analysis, 25% of the variability in BMC for 
height and 12.6% of the variability in LS BMD were explained by serum IFN-γ 



























































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2. Correlation between TB BMD and serum IFN-γ concentration in the OWB 
group (r= 0.36; P< 0.05).  
 
Table 7. Results of stepwise multiple regression analysis with TB and LS bone mineral 
characteristics as dependent variables and BMI and 13 serum inflammatory markers as 
independent variables. 
Group  NWB OWB 
TB BMD BMI – 29.9% 
 BMI, IL-10 – 38.8% 
LS BMD EGF 12.9% – 
 EGF, BMI 21.0% – 
 IFN-γ – 12.6% 
 IFN-γ, IL-4 – 20.5% 
TB BMC BMI 15.3% 14.7% 
 BMI, IL-10 26.3% – 
TB BMAD BMI 12.4% – 
LS BMAD EGF 7.9% – 
BMC for height BMI 24.4% – 
 BMI, IL-10 30.6% – 
 IFN-γ – 25.0% 
R2 × 100 is shown describing the percentage of variability of the dependent variables the 












5.4. Relationships between serum inflammatory markers 
and cardiorespiratory fitness parameters 
The Pearson correlations between 13 inflammatory parameters and VO2peak 
showed that in the OWB group only serum TNF-α concentration correlated 
positively with VO2peak, while IL-6 correlated negatively (P<0.05) with 
VO2peak/kg (Table 8; Figure 3). The other correlations are shown in Table 8.  
 
Table 8. Pearson correlation coefficients between serum biochemical markers and 
VO2peak and VO2peak/kg in the OWB (n=38), NWB (n=38) and total (n=76) groups.  
 VO2peak VO2peak/kg 
NWB OWB Total NWB OWB Total 
IL-2 (pg/ml) 0.016 0.062 0.001 –0.100 0.082 0.060 
IL-4 (pg/ml) –0.149 0.170 0.079 0.143 –0.210 –0.088 
IL-6 (pg/ml) 0.046 0.105 0.242* –0.233 –0.372* –0.470** 
IL-8 (pg/ml) –0.075 0.163 0.181 –0.188 –0.061 –0.270* 
IL-10 (pg/ml) –0.103 0.205 0.103 0.076 –0.178 –0.130 
VEGF (pg/ml) –0.093 –0.141 –0.066 0.035 –0.116 –0.089 
IFN-γ (pg/ml) 0.028 0.261 0.264* 0.180 –0.093 –0.226 
TNF-α (pg/ml) –0.163 0.405** 0.146 –0.180 –0.173 –0.229 
IL-1α (pg/ml) –0.203 0.171 0.172 –0.168 0.079 –0.288* 
IL-1β (pg/ml) –0.156 0.232 0.131 –0.184 0.110 –0.175 
MCP-1 (pg/ml) –0.064 0.054 0.147 –0.036 0.063 –0.255* 
EGF (pg/ml) 0.055 0.028 0.102 –0.099 0.099 –0.026 
hsCRP (mg/L) 0.169 0.221 0.368** –0.051 –0.158 –0.450** 





Figure 3. Correlation between VO peak/kg and serum IL-6 concentration in the OWB 2
group (r= –0.37; P< 0.05). Children in the low OWB group are shown by triangles, in 
the middle OWB group by squares and in the high OWB group by circles.  
 
The stepwise multiple regression analysis showed that BMI, in conjunction with 
IL-6, explained 44.5% of the variability in VO2peak/kg in the OWB group 
(Table 9).  
 
Table 9. Results of stepwise multiple regression analysis with VO2peak/kg and 
VO2peak as dependent variables and BMI and 13 serum inflammatory markers as 
independent variables. 
Group  NW OW 
VO2peak/kg BMI – 38% 
 BMI, IL-6 – 44.5% 
VO2peak TNF-α – 13.8% 
R2 × 100 is shown describing the percentage of variability of the dependent variables the 














6.1. Inflammatory markers and their relationships with 
body composition in overweight and normal weight boys 
In this study, 13 inflammatory markers and their relationships with body fat 
were studied in 10- to 11-year-old OWB, in comparison with NWB. As 
expected, OWB with similar age were taller and more advanced in their 
pubertal development than their NWB counterparts. It is known that obese 
children are taller and their pubertal maturation starts earlier (Heger et al. 2008). 
In OWB, serum IL-6, IL-8, MCP-1, hsCRP, and IFN-γ levels were significantly 
higher than in NWB.  
One of the main findings of the present study was that the T cell-derived 
cytokine IFN-γ, whose serum concentration has not been intensively 
investigated in obese children, was significantly higher in OWB compared to 
NWB. These results are similar to the study by Lee and Choue (2009), who 
found that obese Korean women had significantly higher concentrations of  
IFN-γ compared with normal weight and overweight subjects. The percentage 
of IFN-γ-positive cells in obese children is positively associated with 
nonalcoholic steatohepatitis, insulin, and HOMA-IR values, but not with BMI 
SDS and TB FM (Pacifico et al. 2006). This study found a positive correlation 
between serum IFN-γ concentration, and TB FM % and TB FM in OWB, but 
not with trunk FM % and trunk FM. Thus, the prevalent Th1 pattern of secreted 
cytokines (i.e. IFN-γ) may be regarded as a mechanism contributing to 
inflammation in obesity. Todoric et al. (2011) proposed a possible mechanism 
by which IFN-γ may be involved in the pathogenesis of obesity. Namely, they 
demonstrated that IFN-γ is a potent inhibitor of Hedgehog signalling – an 
inhibitor in white adipocyte differentiation. To the best of our knowledge, no 
other studies have described a positive correlation between TB FM and serum 
IFN-γ levels in children. Interestingly, there was a lack of significant relation-
ships between serum IFN-γ levels and central obesity measured as WC. 
Skinfold thickness on the legs had a significant relationship with IFN-γ in 
OWB. The findings show that IFN-γ is secreted by FM and is responsible for 
some peripheral complications. However, the association between IFN-γ and fat 
parameters does not mean that there is a causative relationship. Serum IFN-γ 
explained some variability of the adiposity in two models achieved from the 
multiple regression analysis. Additional research is required to test this 
assumption. 
Vascular endothelial growth factor is one of the adipose tissue expressed 
bioactive molecules which may be involved in the development of several 
metabolic diseases (Claffey et al. 1992). There are no available data about the 
influence of obesity on VEGF concentration in children. However, increased 
VEGF concentrations in middle-aged obese patients were reduced as visceral fat 
decreased during weight loss (Miyazawa-Hoshimoto et al. 2003). In this study, 
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there were no significant differences in VEGF concentrations between OWB 
and NWB (see Table 2). Serum VEGF concentrations did not correlate with any 
measured anthropometric or body composition parameters. This is rather 
difficult to explain, due to the lack of previous investigations in children. One of 
the explanations may be that VEGF is involved in normal blood vessel 
development and vascular pathogeneses. Pathological changes in the vessels 
may not have developed yet in obese boys, so the role of VEGF is not seen. 
The inflammatory markers IL-6, TNF-α, and CRP, which are more or less 
synthesized in adipose tissue (except for CRP, which is mostly synthesized in 
hepatocytes), have been relatively well-studied in adults. Glowinska and Urban 
(2003) concluded that increased TNF-α and IL-6 in children may confirm the 
process of inflammatory progress already in the early phase of atherosclerosis. 
In the current study, IL-6 and hsCRP were significantly higher in OWB than in 
NWB (see Table 2). Alvarez et al. (2009) found similar results, where IL-6 and 
CRP were associated with body FM characteristics in healthy children ages 7–
12. This study also found that IL-6 and hsCRP concentrations were significantly 
higher in overweight children than in lean children. In addition, multifunctional 
cytokine IL-6 was significantly higher in OWB than in NWB (see Table 2). 
This means that a high serum IL-6 level in OWB may be a predictor of 
developing type 2 diabetes, which is similar to studies in adults (Pradham et al. 
2001; Voller et al. 2004). The mechanism for developing type 2 diabetes is 
thought to be related to reduced insulin action, which is negatively related to 
serum IL-6 concentrations (Vozarova et al. 2001). In other words, high serum 
IL-6 concentrations in obese subjects are associated with reduced insulin-
stimulated glucose disposal. In addition, Ridker et al. (2000) found that elevated 
levels of IL-6 are associated with increased risk of future myocardial infarction.  
It is known that IL-6 can be derived from muscles (Petersen & Pedersen 
2006). As subjects in both groups were matched by everyday physical activity 
level, it is difficult to assume that increased IL-6 levels in OWB were due to 
increased exercise levels. If physical activity levels in these children were 
directly measured, it would likely be higher in the control group. 
All body composition parameters correlated significantly with IL-6 in OWB. 
Only trunk FM correlated significantly in NWB. It is well known that IL-6 
concentration is significantly enhanced by adipose tissue in obese adults (Fried 
et al. 1998). 
There was not a significant difference between groups in TNF-α con-
centration, which is difficult to explain (see Table 2). Interestingly, TNF-α 
correlated with all body composition parameters (including BMI and Sum of 
9 SF) in OWB. However, it is known that TNF-α is only secreted by omental, 
not subcutaneous, fat (Mohamed-Ali et al. 1997). Abdominal SF thickness 
significantly correlated with TNF-α in OWB (r= 0.36, P<0.05). 
There was a higher mean hsCRP concentration in OWB compared to NWB. 
This is similar to Reinehr et al. (2005), McLaughlin et al. (2002), and Ford et al. 
(2001). Serum hsCRP also positively correlated with BMI in OWB, similar to 
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Reinehr et al. (2005) and Hiura et al. (2003). Interestingly, almost all body 
composition parameters (except trunk FM %) only correlated with hsCRP in 
OWB, indicating that hsCRP may play a role in the progression of obesity in 
subjects who are already overweight or obese. Serum hsCRP and TNF-α 
together explained 30.3% of the variability of TB FM in OWB, with no impact 
from age or pubertal stage. 
Trunk FM was significantly correlated with IL-6, TNF-α, and hsCRP. 
Visceral and trunk fat are known risk factors for metabolic syndrome 
(McCarthy 2006; Rosito et al. 2008; Sardinha et al. 2000). This study did not 
directly measure visceral fat, but DXA data about trunk fat are available. 
Sardinha et al. (2000) found that DXA trunk fat and trunk SF were correlated 
with most of the metabolic variables in middle-aged men. In addition, Teixeira 
et al. (2001) showed that DXA- and anthropometry – based whole-body and 
central-fat measures were associated with cardiovascular disease risk factors in 
children. Kaul et al. (2012) concluded that abdominal visceral fat measured by 
DXA could help define diabetes and cardiovascular risk in adults. De Jongh et 
al. (2006) found that visceral (measured by MRI) and trunk adiposity were 
detrimental for capillary perfusion and that this process may start before 
puberty. They also concluded that these observations underline the necessity for 
childhood interventions to prevent trunk obesity as a risk factor for cardio-
vascular diseases (De Jongh et al. 2006). In the current study, trunk FM was 
significantly correlated with IL-6, TNF-α, and hsCRP. In multiple regression 
analysis, 25–26% of the variability of trunk FM or trunk FM % in OWB was 
determined by IL-6 and IFN-γ. Hermsdorff et al. (2010) found that IL-6 and 
TNF-α were significantly higher in those with higher trunk FM. These results 
suggest that these two inflammatory markers may be useful to estimate the risk 
of developing metabolic syndrome in adulthood. 
This study also found that OWB had significantly higher insulin and 
HOMA-IR values, similar to the study by Caballero et al. (2008). Similar results 
were also seen in overweight and normal weight women 38–49 years of age 
(Jürimäe et al. 2009). 
In summary, boys with increased BMI at the beginning of puberty have 
significantly higher serum IL-6, IL-8, MCP-1, hsCRP, and IFN-γ levels. Serum 
IL-6, TNF-α, IFN-γ, and hsCRP also correlated with body composition 
parameters, indicating a link between proinflammatory state and obesity. 
 
 
6.2. Relationships between inflammatory markers and 
bone development in overweight and normal weight boys 
We studied a panel of 13 inflammatory markers in serum and their possible 
relationships with BMD characteristics in overweight 10- to 11-year-old boys in 
comparison with NWB. To our best of knowledge, no studies so far have looked 
the association between a complex of 13 different markers of inflammation and 
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BMD characteristics in overweight children entering puberty. We have shown 
that serum IL-6, IL-8, MCP-1, hsCRP and IFN-γ levels in OWB were 
significantly higher than in NWB (see Table 2). Most of these markers 
correlated significantly with body composition parameters such as TB FM, 
trunk FM, BMI and WC (see Tables 3 and 4), indicating that a low-grade 
inflammatory process is already taking place during the development of 
childhood obesity. For example, FM was positively correlated with serum IL-6, 
IFN-γ, TNF-α and hsCRP levels in OWB. In contrast, FM was not significantly 
correlated to any measured 13 inflammatory markers in the NWB group (see 
Table 4). In the present study we found higher TB and LS BMD and TB BMC, 
but lower TB BMAD in OWB when compared to NWB. The lower TB BMAD 
is most likely due to the higher BA in OWB. Indeed, OWB had significantly 
higher TB BA, in comparison to NWB. This reflects the results reported by 
Goulding et al. (2000) study with children and adolescents. We found OWB to 
have not only more FM, but also FFM. This also corresponds to existing 
literature (El Hage et al. 2011). Increased FM has been found to increase bone 
maturation (El Hage et al. 2009), whereby gains in bone mass size are earlier 
than gains in bone mineral accrual (Bass et al. 1999). Indeed, the overweight 
group of our study was taller, heavier, with higher BMI, and boys were more 
frequently in Tanner stage 2 or 3 in comparison with NWB, suggesting that they 
had grown or matured faster than the normal weight group. Low TB BMAD has 
been found to be associated with increased risk for bone fractures (Dimitri et al. 
2010). However, for our surprise, the current medical history of previous bone 
fractures in our subjects showed a non-significant trend that obese boys have 
less fractures that the NWB. This is difficult to interpret in light of our small 
sample size. However, it may be further compounded by confounders, such as 
the possibility that NWB are more likely to play and behave in ways that put 
them at increased risk of fractures. 
Unfortunately we did not ask from our subjects their everyday dietary 
calcium intake, an important determinant of BMD (Al-Musharaf et al. 2012; 
Santos et al. 2008). However, literature about the role of calcium in obese 
children remains controversial. For example, Al-Musharaf et al. (2012) did not 
find any differences in the daily intake of calcium between overweight and 
normal weight children aged 6 to 17, while Santos et al. (2008) found that 
calcium intake was significantly higher in normal weight 15–17-year-old 
adolescents, when compared to overweight adolescents.  
Our main finding was a positive correlation between serum IFN-γ 
concentration and TB BMD among OWB (see Table 6; Figure 2). When 
excluding from the OWB group the two boys who were only overweight, i.e. 
BMI between 85th and 95th centile, serum IFN-γ concentration also correlated 
significantly to LS BMD. To the best of our knowledge, no studies have 
previously investigated possible relationships between circulating IFN-γ levels 
and TB BMD characteristics in children. Serum IFN-γ concentration was 
positively correlated to FM in our overweight, but not in NWB (see Table 4). 
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Accordingly, IFN-γ may contribute to inflammation in obesity and could be a 
link between increased FM and higher BMD. 
Interferon-γ is a cytokine produced locally in the bone microenvironment by 
cells of immune origin as well as mesenchymal stem cells (Duque et al. 2011). 
In vitro IFN-γ has been shown to suppress osteoclastogenesis and in vivo to 
decrease osteoclast formation by targeting directly osteoclast precursors, but 
indirectly stimulates also osteoclast formation by stimulating antigen-dependent 
T-cell activation and T-cell secretion of the osteoclastogenic factors RANKL 
and TNF-α (Gao et al. 2007). Thus, IFN-γ can both inhibit and stimulate bone 
resorption. IFN-γ receptor knockout mice exhibited a reduction in bone volume 
and significant changes in cortical and trabecular bone structure typical for 
osteoporotic phenotype (Duque et al. 2011). Bone histomorphometry of these 
mice showed a low-bone-turnover pattern with a decrease in bone formation 
and a reduction in circulating levels of bone-formation and bone-resorption 
markers. Furthermore, administration of IFN-γ to wild-type ovariectomized 
female mice significantly improved bone mass and microarchitecture and 
rescued osteoporosis (Duque et al. 2011). Studies in humans have shown that 
the CD4+ cells taken from women with osteoporotic fractures secreted less 
IFN-γ than those cells taken from women with no fractures (Breuil et al. 2010). 
The production of IFN-γ by peripheral blood mononuclear cells has also been 
lower in active Crohn's disease and correlated negatively with bone 
resorption/formation ratio (Trebble et al. 2005), i.e. higher IFN-γ production 
was related to increased bone formation. Thus this literature supports the notion 
that IFN-γ plays a central role in stimulating bone turnover and bone 
accumulation. In our study, 25% of the variability of TB BMC for height and 
12.6% of the variability LS BMD was determined by IFN-γ in the OWB group. 
These findings indicate that elevated IFN-γ in obesity may be a link between 
adipose and bone tissues. However, given the complexity of interplay between 
these three, as well as an absence of time-series data to date, the correlation we 
report does not give evidence for any causative relationship between IFN-γ and 
TB BMD.  
We also found serum IL-10 and hsCRP concentrations to be positively 
correlated with TB BMD in OWB. In addition, we found that serum hsCRP 
concentration was significantly correlated with many parameters of body fat, 
indicating that hsCRP reflects the severity of obesity (see Table 4). This in turn 
may influence bone mineral acquisition in boys entering puberty. However, 
Pollock et al. (2010) did not find significant correlation between CRP and TB 
BMC in overweight 8–9-year-old children. It is known that IL-10 is an 
important endogenous suppressor of infection-stimulated bone resorption in 
vivo (Sasaki et al. 2000), and IL-10 has also been indicated to inhibit the 
differentiation of osteoclasts in vitro (Owens et al. 1996). To the best of our 
knowledge, no previous studies have investigated the possible association 
between IL-10 and TB BMD in children with different BMI values. 
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In summary, despite greater TB BMD, OWB had lower TB volumetric BMD 
compared with NWB and therefore may have increased risk for fractures in 
adulthood. The positive correlation between serum INFγ concentration and TB 
BMD suggest that the inflammatory process, already taking place in the early 
stages of obesity, may also affect bone accumulation. Further studies are needed 
to clarify precisely how INFγ is linked to adipose tissue and bone health in a 
causative manner.  
 
 
6.3. Relationships between inflammatory markers  
and cardiorespiratory fitness in overweight  
and normal weight boys 
The results of our study showed that absolute VO2peak was significantly higher 
and relative VO2peak per kilogram body mass significantly lower in the OWB 
group than in the NWB group. We also found that cardiorespiratory fitness 
characterized by VO2peak (ml/min/kg) was negatively correlated with serum 
IL-6 concentration, while in the OWB group VO2peak (l/min) was positively 
correlated with serum TNF-α level. 
The low-grade systemic inflammation was associated with the body 
composition values, especially with the amount of FM in obese children 
(Alvarez et al. 2009). Proinflammatory cytokines, such as IL-6 and TNF-α, 
were also associated with obesity characteristics (Wärnberg et al. 2010). In our 
study, we found that higher IL-6 was associated with lower cardiorespiratory 
fitness expressed as VO2peak/kg in the OWB group (see Figure 3). This is 
similar to the study by Gaeini et al. (2009), where IL-6 was negatively 
correlated with VO2peak/kg in a group of boys with normal and increased BMI, 
whereas no such correlation was found within the OWB group. This was 
probably due to the fact that the number of overweight subjects (aged 11–14 
years) in that study was quite small: only 10 boys. Kullo et al. (2007) found, 
similarly to our study, that serum IL-6 concentration was negatively associated 
with VO2peak/kg in a group of men (BMI from 22.4 to 44.0 kg/m
2 ). Pischon et 
al. (2003) found that healthy men and women with lower physical activity level 
had higher levels of IL-6 and CRP. In the Kullo et al. (2007) study, reduced 
cardiorespiratory fitness was correlated with increased IL-6 and CRP. In 
addition, Gaeini et al. (2009) suggested that emphasis on physical activity and 
cardiovascular fitness in children is an important factor for prevention of 
atherosclerosis in adulthood. It is known that IL-6 may be a predictor for the 
development of type 2 diabetes (Pradham et al. 2001). In a multiple regression 
analysis, 44.5% of the variability of VO2peak/kg in OWB was determined by 
BMI and IL-6 together. These results suggest that increased serum IL-6 
concentration may be a useful biochemical marker for identifying subjects who 
need specific exercise formats to achieve maximal beneficial health effects from 
exercise and, in the long-term, can reduce their risk for the development of type 
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2 diabetes and atherosclerosis. The exercises that suit the overweight children 
with high serum IL-6 concentrations and therefore with low cardiorespiratory 
fitness levels are regular aerobic exercises like walking and jogging (Zorba et 
al. 2011). In addition, strength training with relatively low intensity is also 
recommended in overweight and obese subjects (McInnis et al. 2003). Whereas 
exercises that usually require high cardiorespiratory fitness level such as high-
intensity exercises are not suitable for overweight children (Lazzer et al. 2011). 
Another finding of our study was that serum TNF-α concentration was 
positively correlated with absolute VO2peak (l/min) in OWB. These results are 
similar to the study by Nemet et al. (2003), who found that, in 12- to 14-year-
old Hispanic and Asian-American normal- and overweight children, 
cardiorespiratory fitness measured by VO2peak was positively correlated with 
TNF-α. In both studies, TNF-α level was higher in subjects with higher body fat 
and with higher muscle mass. Muscle mass has been found to be the major 
determinant of cardiorespiratory fitness (Nemet et al. 2003). In other words, 
subjects with increased BMI and muscle mass have also higher absolute 
cardiorespiratory fitness values and higher serum TNF-α level. In addition, 
TNF-α is produced by adipose tissue and is associated with the development of 
obesity complications such as diabetes and atherosclerosis (Hajer et al. 2008; 
Trayhurn & Beattie 2001). Thus, children with higher BMI and bigger muscle 
mass have a tendency to have higher serum TNF-α levels and this, in turn, 
results in higher absolute VO2peak (l/min) and lower relative VO2peak/kg 
(ml/min/kg) (Nemet et al. 2003). In the long-term, overweight subjects have 
increased risk of developing diabetes and atherosclerosis and therefore the 
increased levels of TNF-α may play a role in the pathogenesis of these 
complications (Hajer et al. 2008; Nemet et al. 2003; Trayhurn & Beattie 2001). 
In our study, cardiorespiratory fitness was measured by absolute VO2peak 
and relative VO2peak/kg. The results of our study showed that VO2peak was 
significantly higher and VO2peak/kg significantly lower in the OWB group. 
These results are similar to the studies by Eliakim et al. (2006), Gaeini et al. 
(2009), and Rosa et al. (2011), where a lower VO2peak/kg was found in 
overweight children compared to the children with normal weight. 
Of the 13 biochemical markers measured in our study, only IL-6 was 
significantly correlated with cardiorespiratory fitness relative to body mass as 
assessed by VO2peak/kg in the OWB group. No significant correlations were 
found between other inflammatory markers and VO2peak/kg in the OWB group. 
To our best knowledge, no studies have previously looked at the associations 
between such a complex of biochemical markers and cardiorespiratory fitness in 
overweight children. Eliakim et al. (2006) studied the association between 
serum IL-1β concentration and VO2peak in children aged 8 to 17 years, but did 
not find a significant correlation between these parameters. Therefore, it is 
likely that other measured markers of inflammation in this study are not 
associated with cardiorespiratory fitness, at least in children. 
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In summary, OWB had lower cardiorespiratory fitness level as measured by 
VO2max/kg and this was negatively correlated with serum IL-6 level. 
Measurement of serum IL-6 level in overweight children may help to identify 
subjects who need specific aerobic exercise formats and levels to achieve 
maximal beneficial health effects and to reduce their risk for the development of 





1.  Significantly higher serum IL-6, IL-8, MCP-1, CRP, and IFN-γ levels were 
seen in overweight boys compared to those with normal BMI at the 
beginning of puberty;  
2.  Serum IL-6, TNF-α, CRP, and IFN-γ levels correlated with body fat charac-
teristics, indicating the link between an inflammatory state and obesity; 
3.  Despite greater total body BMD, overweight boys had lower total body 
apparent (volumetric) BMD compared with normal weight boys, and 
therefore may have increased risk of fractures in adulthood. The positive 
association between serum INF-γ concentration and BMD suggests that the 
inflammatory process already taking place in the early stages of obesity may 
also affect bone accumulation;  
4.  Overweight boys had lower cardiorespiratory fitness levels as measured by 
VO2peak/kg, and this was negatively correlated with serum IL-6 levels. 
Measurement of serum IL-6 levels in overweight boys may help to identify 
subjects who need specific exercise formats to achieve maximum beneficial 
health effects, and to reduce their risk of developing type 2 diabetes and 
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SUMMARY IN ESTONIAN 
Seosed põletikumarkerite, keha koostise,  
luutiheduse, ja kehalise võimekuse vahel 10–11 aastastel  
ülekaalulistel ja normaalkaalulistel poistel 
Sissejuhatus 
Rasvumisel on kahjulik mõju tervisele ja see probleem on ülemaailmseks muu-
tunud ka laste seas. Erinevad uuringud on näidanud, et ülekaalulisus lapseeas 
toob kaasa riski haigestuda erinevatesse südame-veresoonkonna haigustesse 
täiskasvanuna, samas kui suurem kehaline võimekus vähendab neid riske nii 
lastel kui ka täiskasvanutel. Aktiivne eluviis lapsepõlves loob eeldused pare-
maks terviseks täiskasvanuna. Varasemad uuringud on näidanud, et rasvunud 
lastel esineb sagedamini luumurde. Eriti kriitiline aeg on murdeiga, mil toimub 
peamine luukoemassi ülesehitamine ja selle häired võivad põhjustada osteo-
poroosi hilisemas elus. Rasvumise väljakujunemisel on oma kindel koht ka 
mitmesugustel põletikulistel protsessidel, mida saab hinnata mitmesuguste 
põletikunäitajate määramisega vereseerumis. Seetõttu saab neid põletiku-
näitajaid uurides paremini aru, kas ja kuidas põletik mõjutab rasvumise korral 
luu tervist ja kehalist võimekust.  
 
Uurimustöö eesmärk ja ülesanded 
Käesoleva töö eesmärgiks oli uurida 10- ja 11-aastastel poistel kolmeteist 
erinevat põletikumarkerit veres ja uurida seoseid nende markerite ning keha 
koostise, luutiheduse ja kehalise võimekuse vahel. Lähtuvalt üldeesmärgist olid 
ülesanneteks: 
1. uurida erinevate põletikumarkerite kontsentratsioone vereseerumis üle-
kaalulistel ja normaalkaalulistel poistel; 
2.  uurida võimalikke seoseid vereseerumi põletikumarkerite kontsentrat-
sioonide ja keha koostise vahel ülekaalulistel ja normaalkaalulistel poistel; 
3.  uurida seoseid vereseerumi põletikumarkerite kontsentratsioonide ja 
luutiheduse vahel ülekaalulistel ja normaalkaalulistel poistel; 
4.  uurida seoseid vereseerumi põletikumarkerite kontsentratsioonide ja kehalise 
võimekuse vahel ülekaalulistel ja normaalkaalulistel poistel.  
 
Uuritavad ja metoodika 
Uuringus osalesid 76 Tartu ja Tartumaa koolipoissi vanuses 10–11 aastat, kes 
jagati kehamassiindeksi (KMI) järgi kahte gruppi. Ülekaalulisi poisse, kelle 
KMI oli ülalpool 85. protsentiili, osales uuringul 38 ja kontrollgruppi kuulus 38 
normaalkaalus poissi, kelle KMI oli allpool 85. protsentiili. Mitte ühelgi uuri-
taval ei olnud kroonilisi haigusi, samuti ei olnud neil uuringu ajal ühtegi 
haigestumist. Poisid võtsid osa igapäevastest kehalise kasvatuse tundidest 
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koolis. Uuritavad ei muutnud uuringu käigus oma igapäevaseid toitumis-
harjumusi.  
Kõikidel uuritavatel määrati kehamass ja pikkus ning arvutati KMI. Murde-
iga hindasid poisid ise 5 astmesse kasutades selleks spetsiaalseid illustreerivaid 
pildimaterjale Tanneri metoodika järgi. Lisaks mõõdeti 9 nahavoldi paksus ning 
saadud tulemused summeeriti. DXA aparaadiga määrati keha rasvamass, rasva-
vaba mass, rasvamassi protsent, kogu keha ja nimmepiirkonna luukoe mass, 
luukoe pindala ja luutihedus. Lisaks arvutati volumeetriline luutihedus, mis 
võtab arvesse keha suurust.  
Kehalise võimekuse hindamiseks sooritasid uuritavad veloergomeetril testi 
kuni väsimuseni. Mõõdeti poiste keskmist hapniku tarbimist ja arvutati kesk-
mine hapniku tarbimine kilogrammi kehakaalu kohta. Lisaks mõõdeti uurita-
vatel 13 erineva põletikumarkeri tase vereseerumis: interleukiin-2, interleukiin-4, 
interleukiin-6, interleukiin-8, interleukiin-10, vaskulaarse endoteeli kasvufaktor, 
interferoon-γ, tuumor nekroosis faktor-α, interleukiin 1α, interleukiin 1β, mono-
tsüütne kemotaktiline valk-1, epidermaalne kasvufaktor ja C-reaktiivne valk.  
 
Tulemused ja järeldused 
1.  Kolmeteistkümnest mõõdetud põletikumarkerist olid ülekaalulistel poistel 
vereseerumis oluliselt kõrgemad interleukiin-6, interleukiin-8, monotsüütne 
kemotaktiline valk-1, C-reaktiivne valk ja interferoon-γ;  
2.  Mitmed olulised seosed vereseerumi interleukiin-6, tuumor nekroosis faktor-α, 
C-reaktiivne valk ja interferoon-γ taseme ja keha rasvamassi erinevate 
näitajate vahel näitavad seost põletiku ja ülekaalulisuse vahel; 
3.  Vaatamata suuremale kogu keha luutihedusele oli ülekaalulistel poistel 
võrreldes normaalkaaluliste poistega väiksem volumeetriline luutihedus, mis 
kirjanduse andmetel tõstab riski luumurdude tekkeks täiskasvanuna. Posi-
tiivne seos vereseerumi interferoon-γ konsentratsiooni ja luutiheduse vahel 
näitab, et rasvumise põletikuline protsess, mis on käimas juba 10–11 aasta-
selt, võib mõjutada luutiheduse edasist suurenemist; 
4.  Ülekaalulistel poistel oli madalam kehalise võimekuse tase mõõdetuna 
maksimaalse hapnikutarbimisena kilogrammides kehamassi kohta ja see oli 
negatiivselt seotud vereseerumi interleukiin-6 kontsentratsiooniga. Inter-
leukiin-6 taseme määramine vereseerumis võib aidata ülekaaluliste poiste 
seas avastada neid, kellel on kehaline võimekus madalam ja seetõttu vajavad 
spetsiaalseid treeninguid, et saavutada kehalise koormuse maksimaalne 
kasulik mõju tervisele ja vähendada seeläbi nende riski haigestuda 2 tüübi 
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